These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 24794408)

  • 41. Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice.
    Lin SI; Huang MH; Chang YW; Chen IH; Roffler S; Chen BM; Sher YP; Liu SJ
    Cancer Lett; 2016 Jul; 377(2):126-33. PubMed ID: 27130449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human dendritic cells pulsed with specific lipopeptides stimulate autologous antigen-specific T cells without the addition of exogenous maturation factors.
    Jones KL; Brown LE; Eriksson EM; Ffrench RA; Latour PA; Loveland BE; Wall DM; Roberts SK; Jackson DC; Gowans EJ
    J Viral Hepat; 2008 Oct; 15(10):761-72. PubMed ID: 18637077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenicity of a Tripartite Cell Penetrating Peptide Containing a MUC1 Variable Number of Tandem Repeat (VNTR) and A T Helper Epitope.
    Brooks N; Hsu J; Esparon S; Pouniotis D; Pietersz GA
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30200528
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of HLA DR7-restricted epitopes from human telomerase reverse transcriptase recognized by CD4+ T-helper cells.
    Schroers R; Huang XF; Hammer J; Zhang J; Chen SY
    Cancer Res; 2002 May; 62(9):2600-5. PubMed ID: 11980655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [In vitro induction of immune response by dendritic cells pulsed with TRAG-3-derived cytotoxic T lymphocyte epitope].
    Zhu B; Chen ZT; Cheng XM; Wu YZ
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):709-12. PubMed ID: 15733385
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
    Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA
    J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor-reactive T helper lymphocytes recognize a promiscuous MAGE-A3 epitope presented by various major histocompatibility complex class II alleles.
    Kobayashi H; Song Y; Hoon DS; Appella E; Celis E
    Cancer Res; 2001 Jun; 61(12):4773-8. PubMed ID: 11406551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Defining MHC class II T helper epitopes for WT1 tumor antigen.
    Kobayashi H; Nagato T; Aoki N; Sato K; Kimura S; Tateno M; Celis E
    Cancer Immunol Immunother; 2006 Jul; 55(7):850-60. PubMed ID: 16220325
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
    Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
    J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers.
    Bohnenkamp HR; Coleman J; Burchell JM; Taylor-Papadimitriou J; Noll T
    Cell Immunol; 2004; 231(1-2):112-25. PubMed ID: 15919376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved efficacy of therapeutic vaccination with dendritic cells pulsed with tumor cell lysate against hepatocellular carcinoma by introduction of 2 tandem repeats of microbial HSP70 peptide epitope 407-426 and OK-432.
    Ge C; Xing Y; Wang Q; Xiao W; Lu Y; Hu X; Gao Z; Xu M; Ma Y; Cao R; Liu J
    Int Immunopharmacol; 2011 Dec; 11(12):2200-7. PubMed ID: 22015603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response.
    Kissick HT; Sanda MG; Dunn LK; Arredouani MS
    PLoS One; 2014; 9(4):e93231. PubMed ID: 24690990
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.
    Singh R; Singh S; Sharma PK; Singh UP; Briles DE; Hollingshead SK; Lillard JW
    PLoS One; 2010 Feb; 5(2):e9432. PubMed ID: 20195541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
    Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
    Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: dependence on HLA class II restricted T(H) response.
    BenMohamed L; Krishnan R; Longmate J; Auge C; Low L; Primus J; Diamond DJ
    Hum Immunol; 2000 Aug; 61(8):764-79. PubMed ID: 10980387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The regulation of antitumor immune responses by helper T cells--From the bench research to the discovery of H/K-HELP cancer vaccine].
    Nishimura T
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(5):412-23. PubMed ID: 23124083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 mice.
    Cong H; Mui EJ; Witola WH; Sidney J; Alexander J; Sette A; Maewal A; El Bissati K; Zhou Y; Suzuki Y; Lee D; Woods S; Sommerville C; Henriquez FL; Roberts CW; McLeod R
    Hum Immunol; 2012 Jan; 73(1):1-10. PubMed ID: 22027386
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Generation of mammaglobin-A-specific CD4 T cells and identification of candidate CD4 epitopes for breast cancer vaccine strategies.
    Viehl CT; Frey DM; Phommaly C; Chen T; Fleming TP; Gillanders WE; Eberlein TJ; Goedegebuure PS
    Breast Cancer Res Treat; 2008 May; 109(2):305-14. PubMed ID: 17653857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simultaneous activation of T helper function can augment the potency of dendritic cell-based cancer immunotherapy.
    Teramoto K; Ohshio Y; Fujita T; Hanaoka J; Kontani K
    J Cancer Res Clin Oncol; 2013 May; 139(5):861-70. PubMed ID: 23411688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Establishment of HLA-DR4 transgenic mice for the identification of CD4+ T cell epitopes of tumor-associated antigens.
    Yatsuda J; Irie A; Harada K; Michibata Y; Tsukamoto H; Senju S; Tomita Y; Yuno A; Hirayama M; Abu Sayem M; Takeda N; Shibuya I; Sogo S; Fujiki F; Sugiyama H; Eto M; Nishimura Y
    PLoS One; 2013; 8(12):e84908. PubMed ID: 24386437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.